NASDAQ:AMRN Long Term Investor Notice: Investigation of Potential Wrongdoing at Amarin Corporation Plc

An investigation on behalf of current long term investors in Amarin Corporation plc (NASDAQ:AMRN) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

San Diego, CA — (SBWIRE) — 03/09/2022 — An investigation was announced for investors in shares of Amarin Corporation plc (NASDAQ: AMRN) concerning potential breaches of fiduciary duties by certain directors and officers of Amarin Corporation plc.

Investors who are current long term investors in Amarin Corporation plc (NASDAQ: AMRN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm for investors in NASDAQ: AMRN stocks follows a lawsuit filed against Amarin Corporation plc (NASDAQ: AMRN over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: AMRN stocks, concerns whether certain Amarin Corporation plc directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District Court for the District of New Jersey the plaintiff alleges that, the Defendants made false and misleading statements and/or failed to disclose that there was an increasingly high risk that certain of Amarin’s patents would be invalidated, that once certain of Amarin’s patents were invalidated by the United States District Court for the District of Nevada, there was little to no chance of reversing that ruling, that the Company’s litigation was preventing it from effectuating a successful takeover, that Defendants were downplaying the true threat the ongoing Abbreviated New Drug Application (“ANDA”) litigation posed to the Company’s business and future prospects, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.sbwire.com/press-releases/nasdaqamrn-long-term-investor-notice-investigation-of-potential-wrongdoing-at-amarin-corporation-plc-1354342.htm

Media Relations Contact

Michael Daniels
Shareholders Foundation
Telephone: 1-858-779-1554
Email: Click to Email Michael Daniels
Web: https://www.shareholdersfoundation.com/